# Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence

**Authors:** Luiza Cupertino Bérgomi, Giselle de Souza Carvalho, Lucas Zanetti de Albuquerque, Daniel Gonçalves Kischinhevsky, Alexssandra Lima Siqueira dos Santos, Luiza de Freitas Maciel, Isabele Ávila Small, Jessé Lopes da Silva, Andreia C. de Melo, Satyajeet Rath, Satyajeet Rath, Satyajeet Rath

PMC · DOI: 10.1371/journal.pone.0343651 · PLOS One · 2026-03-02

## TL;DR

This study finds that social factors like low education and alcohol use, along with advanced cancer stages, are linked to worse survival in young women with cervical cancer in Brazil.

## Contribution

The paper provides real-world evidence linking social inequities to clinical outcomes in young cervical cancer patients in a public healthcare setting.

## Key findings

- Lower education levels correlate with advanced cancer stages and worse survival outcomes.
- Undifferentiated carcinomas and advanced stages are strongly associated with shorter progression-free and overall survival.
- Alcohol consumption is linked to poorer progression-free survival in young cervical cancer patients.

## Abstract

To assess the influence of social inequities and clinicopathological factors on survival outcomes in young women with cervical cancer treated at a comprehensive public cancer center in Brazil.

This retrospective analysis reviewed the medical records of women aged 18–39 diagnosed with cervical cancer at the Brazilian National Cancer Institute between January 2017 and December 2021, assessing demographic characteristics and survival outcomes.

This analysis included 475 patients with a mean age of 33.6 years, with the majority being non-white (67.7%), never married women (68.0%), and having a low education level (< 8 years) (86.1%). Multivariate analysis indicated that a lower education level was associated with advanced stage (p = 0.001). Recurrence or progression occurred in 224 patients (47.2%), mainly as distant metastases (56.7%). The median progression-free survival (PFS) was 19.8 months, with two-year rates of 81.6%, 45.7%, 28.2%, and 6.2% for stages I, II, III, and IV, respectively. Shorter PFS was correlated with lower education level (p = 0.009), alcohol consumption (p = 0.026), undifferentiated carcinoma (p = 0.007), and advanced disease stage (p < 0.001). The median overall survival (OS) was 35.1 months, with five-year rates of 82.9%, 42.7%, 23.7%, and 9.7% for stages I, II, III, and IV, respectively. Factors associated with shorter OS included lower education level (p = 0.005), undifferentiated carcinoma (p = 0.006), and advanced stage (p < 0.001).

Undifferentiated carcinomas and advanced stages negatively influence the prognosis of young women with cervical cancer. Social factors may also be correlated with poorer outcomes, especially alcohol consumption and lower education levels.

## Linked entities

- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** disease (MESH:D004194), small cell carcinoma (MESH:D018288), Cervical cancer (MESH:D002583), alcohol abuse (MESH:D000437), STI (MESH:D012749), carcinoma in situ (MESH:D002278), Adenocarcinoma (MESH:D000230), Cancer (MESH:D009369), Undifferentiated carcinomas (MESH:D002277), obesity (MESH:D009765), 3 tumors (MESH:C565335), Squamous (MESH:D002294), grade 3 tumors (MESH:D008224), metastases (MESH:D009362), hypertension (MESH:D006973), death (MESH:D003643), infection (MESH:D007239), stage IV disease (MESH:D007676), renal dysfunction (MESH:D007674), Human Immunodeficiency Virus infection (MESH:D015658), stage III/IV (MESH:D062706), adenosquamous carcinoma (MESH:D018196)
- **Chemicals:** paclitaxel (MESH:D017239), D-25-61883 (-), Cisplatin (MESH:D002945), carboplatin (MESH:D016190), Alcohol (MESH:D000438)
- **Species:** Human papillomavirus (species) [taxon 10566], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952609/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12952609/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952609/full.md

---
Source: https://tomesphere.com/paper/PMC12952609